Page 360 - EMF–Elektromagnetische Felder
P. 360

99 100
103 104
106 107
Dependent Manner« in: Experimental Gerontology, Vol. 119, Januar 2019, S. 61-73; DOI: 10.1016/j. exger.2019.01.022.
Piechota-Polanczyk, A., Kopacz, A., Kloska, D., Zgrapan, B., Neumayer, C., Grochot-Przeczek, A., Huk, I., Brostjan, C., Dulak, J., Jozkowicz, A.: »Simvastatin Treatment Upregulates HO-1 in Patients with Abdominal Aortic Aneurysm but Independently of Nrf2« in: Oxidative Medicine and Cellular Longevity, Vol. 2018, Nr. 28, März 2018; DOI: 10.1155/2018/2028936.
Smith, R. E., Tran, K., Smith, C. C., McDonald, M., Shejwalkar, P., Hara. K.: »The Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases« in: Oxidative Medicine and Cellular Longevity, Vol. 4, Nr. 4, Dezember 2016, S. 34.
Jang, H. J., Hong, E. M., Kim, M., Kim, J. H., Jang, J., Park, S. W., Byun, H. W., Koh, D. H., Choi, M. H., Kae, S. H., Lee, J.: » Simvastatin Induces Heme Oxygenase- 1 via NF-E2-Related Factor 2 (Nrf2) Activation through ERK and PI3K/Akt Pathway in Colon Cancer« in: Oncotarget, Vol. 7, Nr. 29, 19. Juli 2016, S. 46219-46229; DOI: 10.18632/oncotarget.10078.
Leonardo, C. C., Doré, S.: »Dietary Flavonoids Are Neuroprotective through Nrf2- Coordinated Induction of Endogenous Cytoprotective Proteins« in: Nutritional Neuroscience, Vol. 14, Nr. 5, September 2011, S. 226–236; DOI: 10.1179/1476830511Y.0000000013.
Kumar, H., Kim, I. S., More, S. V., Kim, B. W., Choi, D. K.: »Natural Product- Derived Pharmacological Modulators of Nrf2/ARE Pathway for Chronic Disease« in: Natural Products Reports, Vol. 31, Nr. 1, Januar 2014, S. 109–139.
Baird, L., Dinkova-Kostova, A. T.: »The Cytoprotective Role of the Keap1-Nrf2 Pathway« in: Archives of Toxicology, Vol. 85, Nr. 4, April 2011, S. 241–272.
Gao, B., Doan, A., Hybertson, B. M.: »The Clinical Potential of Nrf2 Signaling in Degenerative and Immunological Disorders« in: Journal of Clinical Pharmacology, Vol. 6, 2014, S. 19–34.
Sandberg, M., Patil, J., D’Angelo, B., Weber, S. G., Mallard, C.: »NRF2-Regulation in Brain Health and Disease: Implication of Cerebral Inflammation« in: Neuropharmacology, Vol. 79, 2014, S. 298–306; DOI: 10.1016/j. neuropharm.2013.11.004.
Seo, H. A., Lee, I. K.: »The Role of Nrf2: Adipocyte Differentiation, Obesity, and Insulin Resistance« in: Oxidative Medicine and Cellular Longevity, Vol. 2013, 2013, 184598.
Pedruzzi, L. M., Stockler-Pinto, M. B., Leite, M. (Jr.), Mafra, D.: »Nrf2-keap1 System Versus NF-κB: The Good and the Evil in Chronic Kidney Disease?« in: Biochimie, Vol. 94, Nr. 12, Dezember 2012, S. 2461–2466; DOI: 10.1016/j. biochi.2012.07.015.
Smolarek, A. K., So, J. Y., Thomas, P. E., Lee, H. J., Paul, S., Dombrowski, A., Wang, C. X., Saw, C. L., Khor, T. O., Kong, A. N., Reuhl, K., Lee, M. J., Yang, C. S.,

   358   359   360   361   362